# Xalkori

NDC: 0069-0507
Generic name: CRIZOTINIB
Labeler / Manufacturer: Pfizer Laboratories Div Pfizer Inc
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: CAPSULE, COATED PELLETS
Routes: ORAL
Marketing started: 20231120

FDA application: NDA217581

## Active ingredients

- CRIZOTINIB: 50 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0069-0507"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0069-0507
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=2a51b0de-47d6-455e-a94c-d2c737b04ff7